YHYanyan Huang

Yanyan Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yanyan Huang has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Gu

    Department of General Medicine, Huashan Hospital, Fudan University, Shanghai, China

    6 shared publications
  • Houguang Zhou

    Department of Geriatrics, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China

    3 shared publications
  • Kunyu Qiu

    Shanghai Putuo District Changzheng Town Community Health Service Center, Shanghai, 200333, China

    3 shared publications
  • Yilei Liu

    Shanghai Putuo District Changzheng Town Community Health Service Center, Shanghai, 200333, China

    3 shared publications
  • Chengwei Hu

    Shanghai Putuo District Changzheng Town Community Health Service Center, Shanghai, 200333, China

    2 shared publications
  • Hong Jin

    Shanghai Stomatological Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Feasibility and preliminary efficacy of a soft robotic glove for hand rehabilitation in early subacute stroke: a pilot investigation

    by Yingnan Lin, Chuankai Wang, Gavin Yin, Yansheng Lin, Jie Gu, Sujing Xu, Xueli Shan, Yanyan Huang, Jie Jia

    Objectives: This pilot study aimed to investigate the feasibility, safety, and preliminary efficacy of a rehabilitation program utilizing Syrebo ™ SY-HR03E soft robotic glove with pneumatic actuators for hand function recovery in patients with early subacute stroke. Methods: A single-blind pilot randomized controlled trial was conducted in an inpatient clinical setting. The intervention was administered 5 days per week for 4 weeks (20 session’s total). During this period, the robotic therapy (RT) group ( n = 10) received 30-min daily sessions with the soft robotic glove, while the conventional therapy (CT) group ( n = 10) received 30-min daily sessions of conventional hand therapy. Both groups additionally participated in an identical 1-h daily conventional rehabilitation program excluding hand training. The outcome measures included the Fugl–Meyer Assessment for the hand (FM-Hand) and upper limb (FM-UL), the modified Barthel index (MBI), and the Brunnstrom stages (BS). Intervention effects were analyzed using two-way repeated-measures ANOVA. Results: All participants completed the intervention without dropouts or adverse events, confirming the feasibility and safety of the protocol. Baseline motor impairment was comparable between groups (FM-Hand: 2.20±1.93 vs. 2.50±2.64; FM-UL: 19.60±14.76 vs. 16.70±14.50). A significant Group × Time interaction was found for the FM-Hand [F(1,18) = 4.743, p < 0.05] and the MBI [F(1,18) = 7.728, p < 0.05]. Simple effects analysis revealed that both groups improved significantly in FM-Hand, while only the RT group showed a significant improvement in MBI after interventions. For the FM-UL, a significant main effect of Time [F(1,18) =24.931, p < 0.001] in both groups was observed without an interaction. In the BS, a significant main effect of Time was found for both hand and upper limb, with only the RT group showing significant within-group improvement for the hand. Conclusions: Syrebo TM SY-HR03E soft robotic glove is a feasible and safe tool for hand rehabilitation in early subacute stroke. The results provide preliminary signals for improving hand function and translating gains into activities of daily living compared to conventional therapy alone. However, because both groups were in the early subacute stage, the observed gains likely reflect a combination of intervention effects and spontaneous recovery. These findings justify further investigation through larger-scale, definitive trials. Trial Registration : ChiCTR2000034614|| http://www.chictr.org.cn/ with the Clinical Trial Registry (2020/07/12).

  • Open Access

    Usability testing of an upper-extremity rehabilitation robot for stroke rehabilitation

    by Yingnan Lin, Hewei Wang, Li Ding, Qingming Qu, Jianghong Fu, Yifang Lin, Jie Gu, Yanyan Huang, Jie Jia

    This study aimed to evaluate the usability and user experience of the FLEXO-Arm1 upper limb rehabilitation robot among stroke survivors and rehabilitation

  • Open Access

    BMI partially mediates the association between the non–HDL-C/HDL-C ratio and depression in obese adults

    by Kunyu Qiu, Yilei Liu, Yan Zhang, Chengwei Hu, Jie Gu, Yanyan Huang

    Depression has become one of the major global public health burdens. In recent years, lipid metabolic abnormalities have garnered increasing attention as potential influencing factors. Among these, the ratio of non-high-density lipoprotein to high-density lipoprotein cholesterol (NHHR) is regarded as an integrated indicator for assessing atherosclerosis risk. Obesity, as a hallmark of metabolic dysregulation, has a complex interplay with depression. This study aimed to investigate the association between NHHR and depression among obese adults and to evaluate the mediating role of body mass index (BMI) in this relationship. This study utilized data from the 2013-2023 National Health and Nutrition Examination Survey (NHANES), ultimately including 13,991 adult participants with BMI ≥ 25 kg/m². NHHR was analyzed both as a continuous variable and by quartiles, while depression was assessed using the PHQ-9 scale. The primary analyses were conducted without weighting to explore within-sample associations, with core analyses including nonlinear fitting and mediation analysis. To assess the robustness of the findings, sensitivity analyses incorporated NHANES sampling weights and complex survey design, applied multiple imputation for missing covariates, and performed stratified analyses to evaluate the generalizability of the results to the representative population. After multivariable adjustment, NHHR showed a significant nonlinear positive association with depression risk. Threshold effect analysis identified NHHR = 2.95 as the inflection point. To the left of this threshold, higher NHHR was significantly associated with increased depression risk (OR = 1.19, 95% CI: 1.06-1.09), whereas the association changed beyond this point. Mediation analysis indicated that 15.81% of the total effect of NHHR on depression was mediated indirectly through BMI (β = 0.0013, 95% CI: 0.0008-0.0018). However, given the cross-sectional design, reverse causality cannot be ruled out. Sensitivity analyses further demonstrated that the association was more pronounced among individuals without diabetes, those with prediabetes, and ever-smoker, with evidence of interaction effects (P for interaction < 0.05). Notably, the core findings were consistent in direction and overall trend with the unweighted analyses, further supporting the robustness of our results, although the effect sizes were not identical. Among obese adults, higher NHHR levels are significantly associated with an increased risk of depression, with BMI partially mediating this relationship and diabetes status and smoking history serving as moderators. These findings suggest that NHHR may provide valuable insight for early intervention in mental health disorders among obese populations.


  • Open Access

    The association between physical activity and depression among weekend catch-up sleepers: results from NHANES 2021–2023

    by Kunyu Qiu, Yilei Liu, Yan Zhang, Jie Gu, Yanyan Huang

    Depression is a prevalent disorder with significant health impacts. Physical activity is known to protect against depression, but its effects may vary in populations with disrupted sleep patterns, such as weekend catch-up sleepers, which refers to participants who sleep longer on weekends than on weekdays. This study examines the dose-response relationship between physical activity and depression in this population. Data from 1,906 participants in the National Health and Nutrition Examination Survey (2021–2023) were analyzed. Physical activity was measured in MET-minutes per week, and depression was assessed using the PHQ-9. Multivariate linear regression, restricted cubic spline, and two-part linear regression models were employed. In the adjusted model, physical activity showed a negative trend with depression, though this association did not reach statistical significance in the fully adjusted model. Stratified analyses revealed stronger associations in women (OR = 0.86, 95% CI: 0.75, 0.99, P = 0.0329) and individuals aged 40–60 years (OR = 0.79, 95% CI: 0.65, 0.97, P = 0.0237). A threshold effect was observed, with physical activity below 2.48 MET-min/1000-wk showing a negative association with depression (OR = 0.69, 95% CI: 0.56, 0.85, P = 0.0006). Beyond this threshold, the relationship changed. A nonlinear relationship between physical activity and depression was identified in weekend catch-up sleepers, with moderate activity levels (2.48 MET-min/1000-wk) offering the greatest mental health benefits, particularly in women and individuals aged 40–60 years. Not applicable.


  • Open Access

    Threshold effects of sleep duration and cognitive function in older adults with BMI ≥ 25 kg/m2

    by Kunyu Qiu, Yilei Liu, Chengwei Hu, Jie Gu, Yanyan Huang

    Background: It has been demonstrated that older adults’ cognitive capacities can be improved with sleep duration. However, the relationship between overweight, obesity, and cognitive decline remains a subject of debate. The impact of sleep duration on cognitive performance in seniors with a body mass index (BMI) ≥ 25 kg/m2 is largely unknown. This makes it an intriguing subject to explore further.Methods: This study used data from the National Health and Nutrition Examination Survey (NHANES) (2011–2014) with 2,243 participants. Weighted multivariate linear regression and smooth curve fitting were employed to investigate linear and non-linear relationships. A two-part linear regression model was used to determine the threshold effects. Additionally, subgroup analysis and interaction tests were conducted.Results: Results showed that a negative association was found between sleep duration and scores in the fully adjusted model in the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) test, the Animal Fluency test (AFT), and the Digit Symbol Substitution test (DSST). A two-piecewise linear regression model was then applied to explore the threshold effect of sleep duration on cognitive performance. When sleep duration was less than 5 and 6 h per day, sleep duration was positively correlated with CERAD test scores [ß (95% CI): 2.11 (1.17, 3.05), p < 0.0001], AFT scores [β (95% CI): 0.25 (−0.17, 0.67), p = 0.2376], and DSST scores [ß (95% CI): 0.49 (−0.57, 1.56), p = 0.3654]. However, there was a threshold effect where sleep duration reached the three inflection points.Conclusion: In overweight and obese older adults, there is a clear inverted U-shaped relationship between sleep duration and cognitive function, with consistent results across different subgroups. Sleep durations of around 5–6 h may help prevent cognitive decline in older adults with a BMI ≥ 25 kg/m2.


  • Open Access

    Effect of Multimodal Intervention in Individuals with Mild Cognitive Impairment: A Randomized Clinical Trial in Shanghai

    by Meixiang Fan, Qingfeng Li, Tingting Yang, Yinghua Yang, Zhihua Chen, Guo Xuan, Ye Ruan, Shuangyuan Sun, Meng Wang, Xiaoli Chen, et al.

    Background: Previous trials have indicated that multimodal training could improve cognitive functions and moods in individuals with mild cognitive impairment (MCI). However, evidence was mainly obtained from studies in high-income countries. Objective: This trial aims to investigate the efficacy, safety, and potential mechanism of a multimodal intervention on cognitive function in individuals with MCI living in a community. Methods: In this single-blind, randomized controlled trial, 120 participants with MCI were randomly assigned to either the intervention group or the control group. The intervention group received the multimodal intervention, while the control group received regular health education. Neuropsychological tests and magnetic resonance imaging (MRI) were conducted at baseline and after the 12-week intervention. Results: Fifty-nine and fifty-seven participants respectively in the intervention and control groups completed the trial. The intervention group shown improvements in primary outcome, Mini-Mental State Exam (MMSE) total score (mean difference –0.96, 95% CI [–1.58, –0.34], p = 0.003), and secondary outcomes: MMSE recall (–0.39, 95% CI [–0.71, –0.07], p = 0.019), MMSE language (–0.26, 95% CI [–0.44, –0.07], p = 0.007), Auditory Verbal Learning Test instantaneous memory (–3.30, 95% CI [–5.70, –0.89], p = 0.008), Digit Symbol Substitution Test total score (–2.91, 95% CI [–5.67, –0.15], p = 0.039), digit span forwards (–1.25, 95% CI [–1.93, –0.56], p < 0.001), and Digit Span Test (–1.33, 95% CI [–2.33, –0.34], p = 0.009) compared to the control group. Improvements were observed in structural and functional connectivity related to language, concentration, executive function, memory, and recall functioning via MRI in the intervention group. Conclusions: The multimodal intervention improved cognitive function in individuals with MCI in cognitive performance and neuroimaging.


  • Open Access

    High dietary intake of unsaturated fatty acids is associated with improved insulin resistance – a cross-sectional study based on the NHANES database

    by Xiaonan Chen, Jie Gu, Yanyan Huang

    Background: A moderate intake of unsaturated fatty acids (UFA) is associated positively with improved insulin resistance. The aim of this study was to investigate the relationship between the dietary intake of unsaturated fatty acids/total fats (UFA/TF) and insulin resistance. Methods: 15,560 participants were selected from the National Health and Nutrition Examination Survey (NHANES) database enrolled between March 2017 and 2020, and excluded those under 20 years of age, pregnant, or with missing data for key research items. Finally, 7,630 participants were included in the study. R software was used for data analysis that included: (1) general descriptive statistics; (2) comparison of differences in baseline information of three UFA/TF groups, namely low, medium, and high ratios; (3) calculation of the correlation between the UFA/TF ratio and markers of insulin resistance: triglyceride-glucose index (TyG) and homeostatic model assessment for insulin resistance (HOMA-IR); (4) stratification of the study subjects into two groups, with or without insulin resistance, using a cut-off value of HOMA-IR ≥ 2, followed by logistic regression analysis to examine the relationship between UFA/TF and insulin resistance status in the two groups; and (5) further stratification of the subjects according to age, gender, body mass index (BMI), race, total energy intake, total protein, total carbohydrate, total sugars, total dietary fiber, total fat, alcohol consumption, diabetes, hypercholesterolemia to analyze the impact of UFA/TF on insulin resistance status in different subgroups. Results: (1) A high UFA/TF level was associated with a low TyG index and HOMA-IR [β (vs. TyG index) = -0.559, 95% CI: (-0.821~-0.297), P < 0.001; β (vs. HOMA-IR) = -0.742, 95% CI: (-1.083~-0.402), P < 0.001]. This negative relationship became more pronounced when UFA/TF exceeded 57.9% (i.e., the higher group). (2) Logistic regression analysis showed that a higher UFA/TF level was associated with a lower risk of developing insulin resistance [Q3 vs. Q1: 0.838 (95%CI: 0.709 ~ 0.991); P for trend = 0.038]. After adjusting for covariates such as gender, age, and BMI, this protective effect remained significant (P value < 0.05). (3) Analysis also showed that increased UFA/TF intake reduced the risk of developing insulin resistance (OR = 0.266, 95% CI: (0.075 ~ 0.946), P = 0.041). Subgroup analysis showed that although elevated UFA/TF intake showed no statistically significant difference in its effect in most subgroups, the large study population in this study provides valuable insights on potential changes. Increased UFA/TF intake may confer relatively greater benefits within specific subgroups, particularly among the elderly [Q3 age group, OR = 0.114, 95%CI: (0.012 ~ 1.078), P = 0.058], females [OR = 0.234, 95%CI: (0.041 ~ 1.333), P = 0.102], those with a BMI ≤ 25 kg/m²[OR = 0.191, 95%CI: (0.016 ~ 2.344), P = 0.196], and individuals without hypercholesterolemia [OR = 0.207, 95%CI: (0.042 ~ 1.013), P = 0.0519]. The impact of high UFA/TF levels within subgroups based on the presence or absence of coronary heart disease and stroke displayed contrasting trends. In those without coronary heart disease, there was a significant protective effect against insulin resistance [OR = 0.254, 95% CI: (0.07 ~ 0.929), P = 0.0384], while in the stroke subgroup, a significantly protective effect against insulin resistance was observed [OR = 0.002, 95%CI: (0 ~ 0.695), P = 0.0376]. Conclusion: A high dietary intake of UFA relative to total fat consumption could be a protective factor against the risk of developing insulin resistance.


  • Open Access

    Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

    by Yan-Mei Wang, Shou-Ling Mi, Hong Jin, Qi-Lin Guo, Zhong-Yu Yu, Jian-Tao Wang, Xiao-Ming Zhang, Qian Zhang, Na-Na Wang, Yan-Yan Huang, et al.

    Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

  • Open Access

    9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

    by Yan-Mei Wang, Shou-Ling Mi, Hong Jin, Qi-Lin Guo, Zhong-Yu Yu, Jian-Tao Wang, Xiao-Ming Zhang, Qian Zhang, Na-Na Wang, Yan-Yan Huang, et al.

    Atherosclerotic cardiovascular disease is a common and severe complication of diabetes. There is a large need to identify the effective and safety strategies on diabetic cardiovascular disease (DCVD). 9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and attenuate inflammation. We aim to evaluate the effects of 9-PAHSA on DCVD and investigate the possible mechanisms underlying it. Firstly, serum 9-PAHSA levels in human were detected by HPLC-MS/MS analysis. Then 9-PAHSA was synthesized and purified. The synthesized 9-PAHSA was gavaged to db/db mice with 50 mg/kg for 4 weeks. The carotid arterial plaque and cardiac structure was assessed by ultrasound. Cardiac autophagy was tested by western blot analysis, electron microscope and iTRAQ. The results showed that 9-PAHSA, in patients with type 2 diabetes mellitus (T2DM), was significantly lower than that in non-diabetic subjects. Administration of 9-PAHSA for 2 weeks reduced blood glucose levels. Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. Electron microscopy showed continue 9-PAHSA treatment significantly increased autolysosomes, while dramatically decreased greases in the myocardial cells of the db/db mice. Moreover, iTRAQ analysis exhibited that continue 9-PAHSA treatment upregulated BAG3 and HSPB8. Furthermore, western blot analysis confirmed that 9-PAHSA down-regulated Akt/mTOR and activated PI3KIII/BECN1 complex in diabetic myocardium. Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy.


  • Open Access

    Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson’s Disease

    by Xiang-Yun Li, Guang-Hai Mei, Qiang Dong, Yu Zhang, Zhuang-Li Guo, Jing-Jing Su, Yu-Ping Tang, Xue-Hong Jin, Hou-Guang Zhou, Yan-Yan Huang

    Aim. In this study we examined the influence of tetrandrine (Tet) on the neuroprotective effects of glutathione (GSH) in the 6-hydroxydopamine- (6-OHDA-) lesioned rat model of Parkinson’s disease (PD).Methods. Levels in the redox system, dopamine (DA) metabolism, dopaminergic neuronal survival, and apoptosis of the substantia nigra (SN) and striatum, as well as the rotational behavior of animals were examined after a 50-day administration of GSH + Tet (or GSH) and/or L-3,4-dihydroxyphenylalanine (L-dopa) to PD rats. Ethics Committee of Huashan Hospital, Fudan University approved the protocol (number SYXK2009-0082).Results. Administration of GSH or Tet alone did not show any significant effects on the factors evaluated in the PD rats. However, in the GSH + Tet group, we observed markedly decreased oxidative damage, inhibition of DA metabolism and enhanced DA synthesis, increased tyrosine hydroxylase- (TH-) immunopositive neuronal survival, and delayed apoptosis of dopaminergic neurons in the SN. Animal rotational behavior was improved in the GSH + Tet group. Additionally, coadministration of GSH + Tet appeared to offset the possible oxidative neurotoxicity induced by L-dopa.Conclusion. In this study, we demonstrated that tetrandrine allowed occurrence of the neuroprotective effect of glutathione probably due to inhibition of P-glycoprotein on 6-hydroxydopamine-lesioned rat models of Parkinson’s disease, including rats undergoing long-term L-dopa treatment.